Acquires Shares of 7601 Celgene Co. (CELG)

Lloyd Doyle
January 14, 2018

TCI Wealth Advisors Inc. now owns 3,043 shares of the biopharmaceutical company's stock worth $395,000 after acquiring an additional 26 shares in the last quarter. The institutional investor held 726,500 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $105.94M, down from 786,700 at the end of the previous reported quarter. Teacher Retirement System Of Texas who had been investing in Synopsys Inc for a number of months, seems to be bullish on the $13.44 billion market cap company. Janus Henderson Group PLC now owns 8,408,961 shares of the biopharmaceutical company's stock worth $1,092,071,000 after purchasing an additional 8,217,433 shares during the last quarter. Synopsys, Inc. (NASDAQ:SNPS) has risen 45.65% since January 13, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Wexford Capital Lp increased Marathon Pete Corp (MPC) stake by 3.68% reported in 2017Q3 SEC filing. Bloombergsen Inc bought 81,200 shares as the company's stock declined 2.93% while stock markets rallied. Bloombergsen Inc who had been investing in Hca Healthcare Inc for a number of months, seems to be bullish on the $31.44 billion market cap company. The stock increased 0.22% or $0.05 during the last trading session, reaching $23.08. The biopharmaceutical company reported $1.91 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.04. HCA Healthcare, Inc. (NYSE:HCA) has risen 7.08% since January 13, 2017 and is uptrending. It has underperformed by 4.69% the S&P500.

Investors sentiment decreased to 1.17 in 2017 Q3. The biopharmaceutical company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.59 by $0.02. It fall, as 44 investors sold CELG shares while 457 reduced holdings. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Prelude Mngmt holds 19,701 shares or 0.26% of its portfolio. Comerica Bank accumulated 96,970 shares or 0.01% of the stock. (NASDAQ:SNPS) for 543,822 shares. State Of Tennessee Treasury Department holds 22,144 shares or 0.01% of its portfolio. Avalon Advisors Ltd Com reported 92,851 shares stake. Eads And Heald Invest Counsel owns 12,063 shares for 1.09% of their portfolio. Chicago Equity Prtn Ltd Liability Corp holds 0.29% or 63,865 shares. Kayne Anderson Rudnick Investment Mgmt Limited invested 0.39% of its portfolio in Celgene Corporation (NASDAQ:CELG). The Switzerland-based Swiss Bancorp has invested 0.48% in Celgene Corporation (NASDAQ:CELG). Berson Corrado Ltd Liability Company invested in 9,792 shares. (NASDAQ:CELG) have been assigned a consensus rating of "Buy" from the thirty-six brokerages that are now covering the stock, MarketBeat.com reports. Therefore 67% are positive.

Tiger Management L.L.C. lowered its stake in shares of Celgene Corporation (NASDAQ:CELG) by 2.7% during the third quarter, Holdings Channel reports. Royal Bank of Canada reaffirmed a "buy" rating and issued a $173.00 price target on shares of Celgene in a research report on Thursday, October 5th. Cantor Fitzgerald downgraded Celgene Corporation (NASDAQ:CELG) on Friday, October 27 to "Neutral" rating. Guggenheim has "Buy" rating and $152.0 target. Canaccord Genuity maintained the stock with "Buy" rating in Thursday, July 27 report. The rating was maintained by Wells Fargo with "Outperform" on Friday, December 4. The stock of Celgene Corporation (NASDAQ:CELG) has "Buy" rating given on Friday, November 6 by UBS. The stock of Celgene Corporation (NASDAQ:CELG) earned "Buy" rating by Jefferies on Thursday, September 14. The company was maintained on Monday, October 10 by. The stock of Celgene Corporation (NASDAQ:CELG) has "Buy" rating given on Thursday, January 14 by Standpoint Research.

Among 12 analysts covering 8×8 (NASDAQ:EGHT), 7 have Buy rating, 0 Sell and 5 Hold. It also reduced its holding in Ishares Core S&P 500Etf (IVV) by 140,933 shares in the quarter, leaving it with 54,081 shares, and cut its stake in Ss&C Technologies Holdings In (NASDAQ:SSNC).


Since August 2, 2017, it had 0 buys, and 5 selling transactions for $6.27 million activity. Shares for $248,498 were sold by Curran Terrie. $2.42M worth of stock was sold by MARIO ERNEST on Thursday, August 10. Another trade for 5,000 shares valued at $384,946 was sold by Logan Joseph W. RUNKEL JOHN F JR also sold $880,000 worth of Synopsys, Inc.

Investors sentiment decreased to 0.83 in 2017 Q3. Its down 0.16, from 1.16 in 2017Q2. 28 funds opened positions while 84 raised stakes. 525.28 million shares or 0.91% more from 520.53 million shares in 2017Q2 were reported. Cornerstone Cap Management Hldgs Llc invested 0.06% of its portfolio in Norfolk Southern Corporation (NYSE:NSC). During the same quarter in the previous year, the business posted $1.58 EPS. equities analysts predict that Celgene Co. will post 6.69 earnings per share for the current year. Los Angeles & Equity Research stated it has 0.02% in HCA Healthcare, Inc. (NYSE:HCA). Pennsylvania-based Veritable Ltd Partnership has invested 0.02% in HCA Healthcare, Inc. Cornerstone Cap holds 1.29% in The Southern Company (NYSE:SO) or 149,682 shares. Eagle Asset Mngmt Inc holds 0.13% or 153,701 shares. Robecosam Ag invested in 0.01% or 800 shares. Public Sector Pension Investment Board has invested 0% of its portfolio in CONMED Corporation (NASDAQ:CNMD). (NYSE:EGHT) for 24,945 shares. It dived, as 15 investors sold EGHT shares while 57 reduced holdings. Amer National Registered Inv Advisor has 0.17% invested in 8×8, Inc. (NYSE:HCA) for 17,268 shares.

Since September 14, 2017, it had 0 buys, and 5 sales for $7.73 million activity. The firm has "Market Perform" rating by Bernstein given on Wednesday, December 27. Hodges Capital Management Inc. bought a new position in Celgene in the 3rd quarter worth approximately $220,000. Jefferies maintained HCA Healthcare, Inc. (NASDAQ:ALDX) rating on Wednesday, September 13. The firm earned "Buy" rating on Monday, July 10 by Cowen & Co. RBC Capital Markets initiated the shares of SNPS in report on Monday, June 6 with "Outperform" rating. The firm has "Buy" rating by H.C. Wainwright given on Monday, September 26. Argus Research maintained HCA Healthcare, Inc. The stock has "Average" rating by Bank of America on Friday, August 28. The stock of HCA Healthcare, Inc. Finally, Morgan Stanley raised Celgene from an "underweight" rating to an "equal weight" rating in a research note on Friday, October 27th.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER